Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  ResMed Inc.    RMD

Delayed Quote. Delayed  - 10/27 04:39:19 pm
60.14 USD   -0.68%
10/26 RESMED : earns $76M in Q1 2017
10/26 RESMED : slips on first quarter income drop
10/26 RESMED INC. (NY : RMD) Files An 8-K Announces Results for the First ..
Analysis summary4-Traders Strategies 

Trading opportunity

share with twitter share with LinkedIn share with facebook
share via e-mail
02/15/2013 | 11:07am
Opinion : Bullish above USD 42.8
Target price : USD 48.4
Stop loss: USD 40.6
Advanced Medical Equipment & Technology

ResMed could regain its upward trend after having run out of steam.

According to Surperformance ratings, the group has strong fundamentals,as shown by the business predictability. In addition, analysts have recently revised upward their earnings estimates and now expect a profit of USD 2.19 per share for the current year.

ResMed is in an uptrend in the medium and long term, but the last bearish movement returns close to a major support level (USD 42.8), level corresponding to the 20-week moving average. This threshold, if preserved, will enable to enjoy the bullish movement towards the USD 48.4 resistance.

It seems opportune to take a long position around the USD 42.8 support area with in line of sight the USD 48.4 resistance. A stop loss must be placed under the USD 42.8 support.

ResMed Inc. : Trading opportunity

© Zonebourse.com 2013
share with twitter share with LinkedIn share with facebook
share via e-mail

Disclaimer: 4-traders.com is a website published by SURPERFORMANCE SAS. Surperformance or 4-traders.com is not a registered broker-dealer nor a registered investment adviser. You understand that this web site and its content is furnished for your personal, noncommercial, informational purposes only, and that no mention of a particular security in this website constitutes a recommendation to buy, sell, or hold any other security, nor that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Surperformance and 4-traders.com services will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. Information regarding trading and investment as provided by Surperformance professional is not tailored to the investment needs of any specific person. You acknowledge that you are responsible for your own financial decisions and should seek a registered financial agent depending on your own risk tolerance to advise you on your personal trading activities.

Designs, manufactures and markets devices for evaluation and treatment of sleep disordersResMed, Inc. engages in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders including sleep... 
More about the company
Financials ($)
Sales 2017 2 069 M
EBIT 2017 487 M
Net income 2017 378 M
Debt 2017 282 M
Yield 2017 2,52%
P/E ratio 2017 22,83
P/E ratio 2018 20,67
EV / Sales 2017 4,26x
EV / Sales 2018 3,90x
Capitalization 8 531 M
More Financials
Duration : Period : Day
ResMed Inc. Technical Analysis Chart | RMD | US7611521078 | 4-Traders
Duration : Period : Week
ResMed Inc. Technical Analysis Chart | RMD | US7611521078 | 4-Traders
Surperformance© ratings  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Earnings quality
Business Predictability
P/E ratio
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
Bollinger Spread
Unusual Volumes
More Ratings